• Home
  • In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.

In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.

Author List
Stock PG, Lantz M, Light S, Vincenti F
Publication
Transplantation proceedings
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1343461
Publication Year
1996
PubMed ID
8623460
Publication Title
Stock PG, Lantz M, Light S, Vincenti F. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients. Transplant Proc. 1996 Apr; 28(2):915-6.